Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madhav V Dhodapkar

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Blood|November 14, 2024
Location, location, location: EMD in MMMadhav V Dhodapkar
Cancer Immunology, Immunotherapy : CII|December 17, 2004
Harnessing host immune responses to preneoplasia: promise and challengesMadhav V Dhodapkar
Blood|January 15, 2011
Protein stress? pDCs go Toll-freeMadhav V Dhodapkar
Blood|November 30, 2011
Adipokines in MM: time to trim the fatMadhav V Dhodapkar
Annals of the New York Academy of Sciences|February 8, 2006
Immune response to premalignancy: insights from patients with monoclonal gammopathyMadhav V Dhodapkar
The Journal of Clinical Investigation|March 5, 2019
Navigating the Fas lane to improved cellular therapy for cancerMadhav V Dhodapkar
American Journal of Hematology|October 4, 2022
The immune system in multiple myeloma and precursor states: Lessons and implications for immunotherapy and interceptionMadhav V Dhodapkar
American Journal of Hematology|June 10, 2009
Myeloid neighborhood in myeloma: cancer's underbelly?Madhav V Dhodapkar
Blood Advances|April 2, 2024
Immune status and selection of patients for immunotherapy in myeloma: a proposalMadhav V Dhodapkar
Blood Advances|July 9, 2024
Understanding CAR-T therapy in myeloma: 1 cell at a timeMadhav V Dhodapkar
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Blood|November 14, 2024
Location, location, location: EMD in MMMadhav V Dhodapkar
Cancer Immunology, Immunotherapy : CII|December 17, 2004
Harnessing host immune responses to preneoplasia: promise and challengesMadhav V Dhodapkar
Blood|January 15, 2011
Protein stress? pDCs go Toll-freeMadhav V Dhodapkar
Blood|November 30, 2011
Adipokines in MM: time to trim the fatMadhav V Dhodapkar
Annals of the New York Academy of Sciences|February 8, 2006
Immune response to premalignancy: insights from patients with monoclonal gammopathyMadhav V Dhodapkar
The Journal of Clinical Investigation|March 5, 2019
Navigating the Fas lane to improved cellular therapy for cancerMadhav V Dhodapkar
American Journal of Hematology|October 4, 2022
The immune system in multiple myeloma and precursor states: Lessons and implications for immunotherapy and interceptionMadhav V Dhodapkar
American Journal of Hematology|June 10, 2009
Myeloid neighborhood in myeloma: cancer's underbelly?Madhav V Dhodapkar
Blood Advances|April 2, 2024
Immune status and selection of patients for immunotherapy in myeloma: a proposalMadhav V Dhodapkar
Blood Advances|July 9, 2024
Understanding CAR-T therapy in myeloma: 1 cell at a timeMadhav V Dhodapkar
Pageof 19